利尿剂难治性腹水的治疗:每日放腹水及输白蛋白与腹水浓缩回输的前瞻性比较

• 作 者: 石碧坚
• 出 处: 国外医学(消化系疾病分册)
• 发表日期: 1990年04期
• 关键词: 难治性腹水 腹水浓缩回输 利尿治疗 水疗法 晚期肝病 安体舒通 腹水感染 细菌性腹膜炎 尿量增多 门诊随访

腹水是晚期肝病的常见并发症,有20%患者控制钠盐饮食和利尿治疗无效。对这些患者可用腹腔-静脉分流或近年来受关注的放腹水疗法。作者应用腹水浓缩回输疗法已近10年。本文为放腹水加输白蛋白与腹水回输两种疗法的前瞻性随机对照比较。病人和方法:难治性腹水的标准为限制水(1500ml/24h)和钠(50 mmol/24h)的摄入,用80 mg速尿和200 mg安体舒通仍无效。40例难治性腹水患者随机分

Ascites is a common complication of advanced liver disease, with 20% of patients controlling the sodium salt diet and diuretic therapy ineffective. Intraperitoneal-venous shunts can be used for these patients or ascites therapy of interest in recent years. The authors apply ascites concentration back to therapy nearly 10 years. This article for ascites plus albumin and ascites transfusion of two kinds of prospective randomized controlled trials. PATIENTS AND METHODS: Refractory ascites is limited by ingestion of water (1500 ml / 24 h) and sodium (50 mmol / h) and is not effective with 80 mg of furosemide and 200 mg of spironolactone. Forty patients with refractory ascites were randomized